IFRXのニュース
FDA Grants Emergency Use Authorization for InflaRx COVID-19 Drug in Critically Ill Patients 2023/04/05 14:52:54 The Epoch Times
Biopharmaceutical company InflaRx NV’s monoclonal antibody has been granted emergency use authorization (EUA) by the Food and Drug Administration (FDA) for the treatment of COVID-19 in hospitalized adults. The FDA said on April 4 that it had issued the EUA for the use of Gohibic, a brand name of vilobelimab, a monoclonal anti-human complement factor C5a antibody, to be injected into hospitalized […]
InflaRx (NASDAQ:IFRX) Stock Spikes: Is There Further Upside? 2023/04/05 10:05:03 TipRanks
Shares of InflaRx (NASDAQ:IFRX) jumped 83.9% on Tuesday, April 4. Further, its stock is up about 11.4% in the pre-market session on Wednesday. Whil…
US stock market closes with a decline, Dow Jones drops by 0.59% 2023/04/05 02:30:00 InstaForex
The number of job vacancies in the US in February fell to its lowest level in almost two years, indicating a cooling labor market, while manufacturing orders fell for the second consecutive month. After the publication of this data, stocks began to fluctuate. Investors were waiting for this statistics to assess the resilience of the economy and get hints about the future increase in interest rates after the recent banking crisis. At the close of the New York Stock Exchange, the Dow Jones index fell by 0.59%, the S&P 500 index dropped by 0.58%, and the NASDAQ Composite index fell by 0.52%. Among the growth leaders of the components of the Dow Jones index at the end of today''s trading were shares of Nike Inc (NYSE:NKE), which appreciated by 2.02 points (1.66%), closing at 123.69. Amgen Inc (NASDAQ:AMGN) quotes increased by 3.09 points (1.26%), finishing trading at 247.53. Walgreens Boots Alliance Inc (NASDAQ:WBA) shares rose in price by 0.39 points (1.10%), closing at 35.85. The leaders in decline were shares of Caterpillar Inc (NYSE:CAT), the price of which fell by 12.42 points (5.40%), closing the session at 217.45.
Inflarx NV PT Lowered to $6 at H.C. Wainwright 2023/01/06 12:00:02 Investing.com
https://www.investing.com/news/pro/inflarx-nv-pt-lowered-to-6-at-hc-wainwright-432SI-2974619
InflaRx Soar after Amending COVID-19 Treatment Agreement 2022/12/21 18:22:49 TipRanks
Shares of InflaRx (NASDAQ:IFRX) are surging higher today, which can be attributed to the company amending its agreement with Staidson BioPharmaceut…
Inflarx NV PT Lowered to $6 at H.C. Wainwright 2023/01/06 12:00:02 Investing.com
https://www.investing.com/news/pro/inflarx-nv-pt-lowered-to-6-at-hc-wainwright-432SI-2974619
InflaRx Soar after Amending COVID-19 Treatment Agreement 2022/12/21 18:22:49 TipRanks
Shares of InflaRx (NASDAQ:IFRX) are surging higher today, which can be attributed to the company amending its agreement with Staidson BioPharmaceut…
Inflarx NV PT Raised to $8 at Raymond James 2022/11/10 12:05:13 Investing.com
https://www.investing.com/news/pro/inflarx-nv-pt-raised-to-8-at-raymond-james-432SI-2939730
Inflarx NV PT Raised to $8 at H.C. Wainwright 2022/08/08 10:52:04 Investing.com
https://www.investing.com/news/pro/inflarx-nv-pt-raised-to-8-at-hc-wainwright-432SI-2866505
If You’re Considering Buying InflaRx N.V. (NASDAQ: IFRX) Stock, Read This First. 2022/06/18 12:00:00 Stocks Register
InflaRx N.V. (NASDAQ:IFRX) price on Friday, June 17, fall -3.20% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.21. A look at the stock’s price movement, the close in the last trading session was $1.25, moving within a range at $1.12 and $1.31. The beta value (5-Year … If You’re Considering Buying InflaRx N.V. (NASDAQ: IFRX) Stock, Read This First. Read More »
Inflarx NV PT Raised to $8 at Raymond James 2022/11/10 12:05:13 Investing.com
https://www.investing.com/news/pro/inflarx-nv-pt-raised-to-8-at-raymond-james-432SI-2939730
Inflarx NV PT Raised to $8 at H.C. Wainwright 2022/08/08 10:52:04 Investing.com
https://www.investing.com/news/pro/inflarx-nv-pt-raised-to-8-at-hc-wainwright-432SI-2866505
If You’re Considering Buying InflaRx N.V. (NASDAQ: IFRX) Stock, Read This First. 2022/06/18 12:00:00 Stocks Register
InflaRx N.V. (NASDAQ:IFRX) price on Friday, June 17, fall -3.20% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.21. A look at the stock’s price movement, the close in the last trading session was $1.25, moving within a range at $1.12 and $1.31. The beta value (5-Year … If You’re Considering Buying InflaRx N.V. (NASDAQ: IFRX) Stock, Read This First. Read More »
InflaRx (IFRX) presents at H.C. Wainwright Global Investment Conference - Slideshow (NASDAQ:IFRX) 2022/05/24 18:59:36 Seeking Alpha
The following slide deck was published by InflaRx N.V.
Read Why Did Raymond James Slash Price Target On Inflarx 2022/05/13 17:55:11 Benzinga
Raymond James remains a Strong Buy on Inflarx NV (NASDAQ: IFRX ) following 1Q22 earnings based on a promising outlook for vilobelimab in Pyoderma Gangrenosum (PG) and potentially other indications. The biotech macro backdrop has forced many companies to be prudent with cash runway and prioritize clinical programs. InflaRx is also focusing on a potential pivotal trial in PG, halting (for now) hidradenitis suppurativa (HS) and ANCA … Full story available on Benzinga.com